JGIA
RMD icon

Jackson Grant Investment Advisers’s ResMed RMD Stock Holding History

Jackson Grant Investment Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9
Closed -$1.78K – 407
2024
Q1 		$1.78K Hold
9
– – ﹤0.01% 367
2023
Q4 		$1.55K Hold
9
– – ﹤0.01% 366
2023
Q3 		$1.33K Hold
9
– – ﹤0.01% 373
2023
Q2 		$1.97K Hold
9
– – ﹤0.01% 369
2023
Q1 		$1.97K Buy
+9
New +$1.95K ﹤0.01% 392

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jackson Grant Investment Advisers's RMD Position: Q2 2024 in Review

Jackson Grant Investment Advisers sold out of ResMed (RMD) in Q2 2024, closing a stake of 9 shares — an estimated $1.78K sold.

Jackson Grant Investment Advisers first reported a position in RMD in Q1 2023 and held it in 5 quarters. The position peaked at $1.97K in Q1 2023. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Jackson Grant Investment Advisers reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 9 ResMed shares in Q2 2024, an estimated $1.78K.
  • Jackson Grant Investment Advisers first reported a position in ResMed in Q1 2023 and held it in 5 quarters.
  • Jackson Grant Investment Advisers's ResMed position peaked at $1.97K in Q1 2023.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2024, filed 16 Jul 2024.